The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ml-RECIST: Machine learning to estimate RECIST in patients with NSCLC treated with PD-(L)1 blockade.
 
Kathryn Cecilia Arbour
Consulting or Advisory Role - AstraZeneca
 
Luu Anh Tuan
No Relationships to Disclose
 
Hira Rizvi
No Relationships to Disclose
 
Adam Yala
Patents, Royalties, Other Intellectual Property - Massachusetts Institute of Technology
 
Matthew David Hellmann
Stock and Other Ownership Interests - Shattuck Labs
Honoraria - AstraZeneca; Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech; Janssen; Merck; Mirati Therapeutics; Nektar; Novartis; Shattuck Labs; Syndax
Research Funding - Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - A patent has been filed by Memorial Sloan Kettering (PCT/US2015/062208) for the use of tumor mutation burden for prediction of immunotherapy efficacy, and which is licensed to Personal Genome Diagnostics. (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Regina Barzilay
Honoraria - Amgen; Novartis
Consulting or Advisory Role - Janssen
Research Funding - Amgen; Bayer; Janssen; Lilly; Merck; Novartis; Sunovion
Travel, Accommodations, Expenses - Bayer; Janssen